COVID-19: CSIR institute to conduct clinical trials of antiviral drug Umifenovir

The CSIR -- Central Drug Research Institute (CDRI) Lucknow, has got the nod for carrying out clinical trial of antiviral drug Umifenovir for treating coronavirus patients, according to a statement. The Phase III clinical trials will be carried out at King George's Medical University (KGMU), Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) and ERA's Lucknow Medical College & Hospital, Lucknow, it added.

from IndiaTV India: Google News Feed https://ift.tt/2UZxa6f

Get Breaking news, Live news, and latest news from India and around the world on INDILIVENEWS.com, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News